The director of the group developing a COVID-19 vaccine candidate at Oxford University says it’s possible that the vaccine could be ready by Christmas.
According to a Reuters report, Oxford vaccine trial chief investigator Andrew Pollard said he’s optimistic that the university, which is collaborating with AstraZeneca on the vaccine, will present trial results by the end of 2020.
The trial hit a slight snag in September when AstraZeneca voluntarily paused the U.S. trial after a standard review process was triggered so an independent committee could review safety data surrounding an unexplained illness that occurred in the UK Phase III trial for the AZD1222 vaccine candidate. Last month, the FDA expanded its probe into the British drugmaker.
Get the full story at our sister site, Drug Discovery & Development.